Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
about
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmissionGene expression profile of AIDS-related Kaposi's sarcomaHIV and the chemokine system: 10 years later.Clinical significance of HIV-1 coreceptor usage.HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAccelerated immunodeficiency by anti-CCR5 treatment in HIV infectionFull-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombinationDefining the fitness of HIV-1 isolates with dual/mixed co-receptor usageConvergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progressionNet positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispeciesNaïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract.Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaquesConstrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.Distribution of CCR5delta32 in human immunodeficiency virus-infected children and its relationship to disease course.Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.Virus population homogenization following acute human immunodeficiency virus type 1 infectionIntrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.Mechanisms of Host Resistance Against HIV Infection and Progression to AIDS.Persistence and emergence of X4 virus in HIV infection.How does HIV-1 infect a susceptible human cell?: Current thinkingIncreased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa.Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child.Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptaseRapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaquesPreferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.HIV-1 sequence evolution in vivo after superinfection with three viral strains.Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homingCellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaquesHIV-1 selection by epidermal dendritic cells during transmission across human skin.Comparison of plasma viremia and antibody responses in macaques inoculated with envelope variants of single-cycle simian immunodeficiency virus differing in infectivity and cellular tropism.
P2860
Q24682756-3C9523A1-1DF1-43C1-B67B-858F568DCF69Q24797857-E196C841-5292-4135-BE23-C0873203F562Q27473020-130E57B4-F7A7-48A6-8540-44E6E4CA53CEQ27691426-843304CF-B239-492C-952D-3D82A8D7436AQ28344746-66888264-E529-4CFC-A0CC-A2FDF265CD4BQ28475890-EBBB7964-A31A-4859-A92E-104E34BA17C5Q29616724-4016E333-5E0D-41DC-9CEB-BB97EF580CF5Q30278577-B7BE0A6A-0679-438B-B208-6575B1B7E6C4Q30416671-030627DD-8356-4278-8A30-642D1C6DE943Q33369086-F248BF9E-D6CC-4350-9446-8856636DBE36Q33638001-D4885083-B992-45A3-83DC-B48E7DBC33E6Q33780524-73F07A00-34AD-484F-9092-0AAAFE2D7678Q33784629-E14A3D21-EF3E-4B93-8341-FC2CA7D4D6E8Q33784940-B438E307-A39F-49D8-A1CA-3221B0A2ED0FQ33788810-0EAB666D-ED30-472D-BC99-2D013AC557CBQ33815654-B463B28E-362A-42DD-B81D-C4AAB7917D2DQ33841288-1D56C800-CA3E-4371-ABDF-3F9C63445CDBQ33857491-33999B37-568B-4F65-B0E5-CEC9AA1C6448Q33887160-DF60A1CC-607B-4E4F-9B05-ABBC5A3C9CA6Q33993065-FE6EA6A6-A9D1-4902-8849-2D891FBDF4D0Q34357324-E4D94B40-7786-4171-B734-D1E0EE2B412BQ34360562-960AC923-043F-4ABA-BDC0-5028964B5A6DQ34553676-D88AE2F7-5D41-4F3D-BDF9-A8C254808F4CQ34783243-A3AF1C30-1359-49BA-955A-EC1958832099Q35055322-A33C068D-E368-49B4-A163-54D1532A2BA5Q35217312-05323729-C12E-4A3F-B4A0-C5431ECCAC38Q35634988-99BC315F-A068-45B9-9960-3B68C4E75A46Q35697724-35C440BD-9D39-48C3-8121-AA92EA6331CEQ35818419-87D8D2C5-CEB1-43C5-AEFD-F9811DE41B65Q35837619-045A048C-6274-41C2-A33B-256D8ABAA220Q35848446-0E5E51E5-51D8-487F-9ED8-66374C6ED1E8Q35866696-0A9114B8-BB42-4E01-AE30-A5C5786D8445Q35871314-392274CD-7AFD-45CA-9145-0CF77C11A4B4Q35978751-E71A2B31-C67B-4996-8181-F1DBC65B5D54Q36011358-31A4794D-0721-481B-9821-9DB407B0667AQ36062983-3ACA3DA9-7BE7-45CA-BA50-20433A1AE8CDQ36148331-C19AF609-1C7D-4457-A2EE-8E2723C2F519Q36366154-BC0C956E-FAF9-4E08-9EF2-B1554A71843AQ36400855-E16D69F3-FC7B-467B-BDEA-E0113A326C68Q36423977-CD8E73C2-AF77-49CF-B61B-4A30A6981688
P2860
Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Syncytium-inducing (SI) phenot ...... nodeficiency virus population.
@ast
Syncytium-inducing (SI) phenot ...... nodeficiency virus population.
@en
type
label
Syncytium-inducing (SI) phenot ...... nodeficiency virus population.
@ast
Syncytium-inducing (SI) phenot ...... nodeficiency virus population.
@en
prefLabel
Syncytium-inducing (SI) phenot ...... nodeficiency virus population.
@ast
Syncytium-inducing (SI) phenot ...... nodeficiency virus population.
@en
P2093
P2860
P1433
P1476
Syncytium-inducing (SI) phenot ...... unodeficiency virus population
@en
P2093
Cornelissen M
Coutinho R
Mulder-Kampinga G
Veenstra J
Zorgdrager F
van der Hoek L
P2860
P304
P407
P577
1995-03-01T00:00:00Z